The Gordian TroClose™ 1200 developed by Gordian Surgical™ is a novel integrated port closure system.
The TroClose 1200 offers surgeons a simple, secure, and safe solution to open and close the abdominal wall during laparoscopic procedures.
Instead of inserting closure sutures in the fascia at the end of a procedure, the TroClose 1200’s uniquely designed “two-in-one” port closure system efficiently inserts sutures into the tissue surrounding the cannula at the beginning of the procedure. When the cannula is removed, the surgeon closes the fascia by simply tying the TroClose 1200 sutures together.
Gordian’s TroClose 1200 can be adapted to all types of trocars: bladed/bladeless, disposable/multiuse, and others.
Founded: November 2012
Investors: The Trendlines Group, B. Braun, private investment funds (China and Canada), private investors, including key opinion leaders (surgeons)
IP: 3 U.S. patents; one provisional, one in National phase
Regulatory: FDA and CE clearance; clearance in Israel and Mexico
Distribution: 6 agreements (U.K., France, Turkey, Greece, Mexico, Panama), monthly shipments; other agreements in negotiation
An estimated 10 million laparoscopic procedures are performed annually. While laparoscopic surgeries are less invasive, closing abdominal access ports remains a difficult and time-consuming task. Today, surgeons manually suture ports with a needle and thread, adding up to 20 minutes per operation. Some surgeons use a dedicated closure device, rather than needle and thread, adding significantly to procedure cost and presenting safety problems.
The global trocar and closure markets are estimated at a combined US$1.45 billion yearly revenue (Medical Market and Technology Reports, MeddeviceTracker). According to MarketStrat, J&J dominates the trocar market (50%), followed by Covidien (30%) and Applied Medical (15%).
Marketing Director Doni Mayerfeld interviewed on ILTV.
CEO Zvi Peer presents at Trendlines 7th Annual Company Showcase in 2017.
See the company 1-page description in Chinese (PDF).
See the Gordian presentation (PDF).
Minimally invasive treatment of heart valve disease
A more efficient ablation catheter to treat atrial fibrillation
Preventing the development of pressure sores
Novel treatment for vertebral compression fractures
Preventing catheter-associated urinary tract infections (CAUTIs)
Wireless, wearable vital sign monitoring system
Cryotherapy for superficial bladder cancer